title: Treatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B - A pilot prospective study.
abstract: OBJECTIVE
  The purpose of this study was to investigate the efficacy and safety of 0.1% tacrolimus powder in Oraguard-B for the treatment of patients with symptomatic oral lichen planus (OLP).
  
  
  METHODS
  This was a nonrandomized, nonblinded study conducted in the outpatient department. The 20 patients with symptomatic OLP oral lichen planus who were asked to participate in the study were provided with 20-g containers of the study medication. Patients were asked to use the medication over the symptomatic areas three times a day until resolution of the lesion. Patients were recalled to assess the drug response every 15 days.
  
  
  RESULTS
  The duration of treatment ranged from 30 to 183 days, with a mean of 81.8 ± 44.4 days; all 20 patients reported a favourable response to the topical tacrolimus therapy. Eleven patients had complete resolution of their lesions. In 16 of 20 patients, there was marked resolution in symptoms as recorded by visual analogue scale. Out of 10 patients followed up for a period of 3 months, 5 had recurrence of their lesions but with less intensity, and the patients were symptomless. No serious side effects were associated with the study medication.
  
  
  CONCLUSIONS
  Topical tacrolimus 0.1% in Oraguard-B was effective and safe in treating patients with OLP. However, there is still a need to undertake more detailed and objective clinical studies to determine the exact benefit of tacrolimus compared with conventional therapies and examine the influence of different dose regimes and formulations and assess the incidence of recurrence.
authors: Department of Oral Medicine, Diagnosis & Radiology, Shree Bankey Bihari Dental College & Hospital, 0.5 Km Ahead of Masuri Canal, Ghaziabad 201302, Uttar-Pradesh, India.
authors: Upender
authors: U
authors: Malik
authors: Siddharth
authors: S
authors: Gupta
authors: Shilpa D
authors: SD
authors: Malik
authors: Shirin
authors: S
authors: Vashishth
authors: Zaheeruddin
authors: M S
authors: MS
authors: Raju
keywords: Oraguard-B; Oral lichen planus; Topical tacrolimus
references: Aust Dent J. 2002 Dec;47(4):290-7
references: 12587763
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103 Suppl:S25.e1-12
references: 17261375
references: Allergy Asthma Proc. 2006 Nov-Dec;27(6):523-6
references: 17176789
references: J Prosthet Dent. 2007 May;97(5):252-5
references: 17547941
references: Ann Allergy Asthma Immunol. 1999 Sep;83(3):179-89; quiz 189-90
references: 10507260
references: Hepatology. 2002 Dec;36(6):1446-52
references: 12447871
references: Dermatology. 2007;215 Suppl 1:45-54
references: 18174692
references: Oral Dis. 2005 Nov;11(6):338-49
references: 16269024
references: J Am Acad Dermatol. 2002 Jan;46(1):27-34
references: 11756942
references: J Cutan Med Surg. 2005 Apr;9(2):43-6
references: 16392010
references: J Am Acad Dermatol. 2002 Jan;46(1):35-41
references: 11756943
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Dec;102(6):744-9
references: 17138176
references: Dent Clin North Am. 2005 Jan;49(1):77-89, viii
references: 15567362
references: Arch Dermatol. 2002 Oct;138(10):1335-8
references: 12374539
references: J Am Acad Dermatol. 2002 Oct;47(4):617-20
references: 12271312
references: J Periodontol. 2004 Apr;75(4):613-9
references: 15152828
references: Eur J Surg Oncol. 1999 Oct;25(5):520-3
references: 10527601
references: Dermatol Clin. 2003 Jan;21(1):79-89
references: 12622270
references: Arch Dermatol. 2004 Dec;140(12):1508-12
references: 15611431
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Mar;95(3):291-9
references: 12627099